HCA Holdings, Inc. (NYSE:HCA) shares increased 0.21% in last trading session and ended the day at $76.02. HCA Gross Margin is 83.10% and its has a return on assets of 6.90%. HCA Holdings, Inc. (NYSE:HCA) quarterly performance is -18.90%.
HCA Holdings, Inc. (NYSE:HCA) said it now expects earnings per share for the third quarter of $1.17, up a penny from the same period a year earlier but below the average analyst estimate of $1.22 on Thomson Reuters. The hospital operator sees revenue rising to $9.856 billion from $9.220 billion a year ago. Analysts, on average, were expecting $9.85 billion in revenue.
XO Group Inc. (NYSE:XOXO) ended the last trading day at $14.23. Company weekly volatility is calculated as 2.51% and price to cash ratio as 4.36. XO Group Inc. (NYSE:XOXO) showed a weekly performance of -2.80%.
On 2 October, XO Group Inc. (NYSE:XOXO), announced the acquisition of GigMasters, a leading transactional marketplace for entertainment. A strategic partnership with Jetaport, a transactional marketplace providing discounted hotel room blocks.
On 14 October, Ultratech, Inc. (NASDAQ:UTEK) shares increased 0.71% and was closed at $15.53. UTEK EPS growth in last 5 year was -56.70%. Ultratech, Inc. (NASDAQ:UTEK) year to date (YTD) performance is -16.33%.
Ultratech, Inc. (NASDAQ:UTEK) announced that it has received a large multiple-system order from a leading semiconductor manufacturer for its advanced packaging AP300 lithography systems. The AP300 systems will be utilized for high-volume, fan-out wafer-level packaging (WLP) applications used to manufacture leading-edge chips. Ultratech will begin shipping the systems in Q4FY15 to the customer’s facility in Taiwan.
Regenxbio Inc. (NASDAQ:RGNX) shares fell -1.76% in last trading session and ended the day at $17.89. RGNX Gross Margin is 86.10% and its has a return on assets of -55.50%.
On 1st October, REGENXBIO Inc. (NASDAQ:RGNX), announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to REGENXBIO’s investigational gene therapy product candidate RGX-111 for the treatment of mucopolysaccharidosis Type I (MPS I).
Energy Transfer Equity, L.P. (NYSE:ETE) caters to the Basic Materials space. It has a net profit margin of 1.70% and weekly performance is -7.61%. On the last day of trading company shares ended up at $22.81. Energy Transfer Equity, L.P. (NYSE:ETE) distance from 50-day simple moving average (SMA50) is -12.67%.
On September 28, 2015, Energy Transfer Equity, L.P. (NYSE:ETE), Energy Transfer Corp LP (“ETC”), ETE Corp GP, LLC (“ETC GP”), LE GP, LLC (“LE”), Energy Transfer Equity GP, LLC (“ETE GP”) and The Williams Companies, Inc. (“Williams” or “WMB”) entered into an Agreement and Plan of Merger (the “Merger Agreement”). The Merger Agreement provides that WMB will be merged with and into ETC (the “Merger”), with ETC surviving the Merger. ETE formed ETC as a limited partnership that will elect to be treated as a corporation for U.S. federal income tax purposes.
Leave a Reply